Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats

References

• Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995; 12: 413–420
   PubMed Web of Science ®Google Scholar
• Benet LZ, Cummins CL, Wu CY. Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. International Journal of Pharmaceutics 2004; 11: 3–9
   Google Scholar
• Dowty ME, Dietsch CR. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability. Pharmaceutical Research 1997; 14: 1792–1797
   PubMedGoogle Scholar
• Fang J, McCallum R, DiBaise J, Schmitt C, Kipnes M. Effects of mitemcinal fumarate (GM-611) on gastric emptying inpatients with idiopathic or diabetic gastroparesis. Gastroenterology 2004; 126: A483
   Google Scholar
• Harrison A, Betts A, Fenner K, Beaumont K, Edgington A, Roffey S, Davis J, Comby P, Morgan P. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations. Drug Metabolism and Disposition 2004; 32: 197–204
   PubMed Web of Science ®Google Scholar
• Hellriegel ET, Bjornsson TD, Hauck WW. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clinical Pharmacology and Therapeutics 1996; 60: 601–607
   PubMed Web of Science ®Google Scholar
• Hoffman DJ, Seifert T, Borre A, Nellans HN. Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling. Pharmaceutical Research 1995; 12: 889–894
   PubMed Web of Science ®Google Scholar
• Kato M, Chiba K, Hisaka A, Ishigami M, Kayama M, Mizuno N, Nagata Y, Takakuwa S, Tsukamoto Y, Ueda K, Kusuhara H, Ito K, Sugiyama Y. The intestinal first-pass metabolism of substrates of CYP3A4 and P-glycoprotein-quantitative analysis based on information from the literature. Drug Metabolism and Pharmacokinetics 2003; 18: 365–372
   PubMedGoogle Scholar
• Koga H, Sato T, Tsuzuki K, Onoda H, Kuboniwa H, Takanashi H. Potent, acid-stable and orally active macrolide-type motilin receptor agonist, GM-611 and the derivatives. Bioorganic & Medicinal Chemistry Letters 1994; 4: 1347–1352
   Google Scholar
• Latini R, Bonati M, Marzi E, Tacconi MT, Sadurska B, Bizzi A. Caffeine disposition and effects in young and one-year old rats. Journal of Pharmacy and Pharmacology 1980; 32: 596–599
   PubMed Web of Science ®Google Scholar
• McCallum RW, Cynshi O and US Investigative Team. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: A randomized, multi-center, placebo-controlled trial. Alimentary Pharmacology and Therapeutics 2007; 26: 107–116
   PubMed Web of Science ®Google Scholar
• Ozaki K, Sudo H, Onoma M, Kamei K, Akima M, Koga H, Itoh Z, Õmura S, Takanashi H. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs. Pharmacology 2007; 79: 223–235
   PubMed Web of Science ®Google Scholar
• Sabath LD, Lorian V, Gerstein D, Loder PB, Finland M. Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Applied Microbiology 1968; 16: 1288–1292
   PubMedGoogle Scholar
• Takanashi H, Yogo K, Ozaki K, Koga H, Itoh Z, Õmura S. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant nonpeptide motilin receptor agonist, in smooth muscle of rabbit small intestine. Pharmacology 2007; 79: 137–148
   PubMedGoogle Scholar
• Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, Murakami T. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. European Journal of Pharmacology 1998; 358: 289–294
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. Pharmaceutical Research 2006; 23: 1460–1472
   PubMed Web of Science ®Google Scholar
• Tamai I, Saheki A, Saitoh R, Sai Y, Yamada I, Tsuji A. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 108–115
   PubMed Web of Science ®Google Scholar
• Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). Journal of Pharmacology and Experimental Therapeutics 1992; 263: 840–845
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Molecular Carcinogenesis 1995; 13: 129–134
   PubMed Web of Science ®Google Scholar
• Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clinical Pharmacology and Therapeutics 1998; 64: 123–128
   PubMed Web of Science ®Google Scholar
• Yogo K, Ozaki K, Takanashi H, Koto M, Itoh Z, Õmura S. Effects of motilin and mitemcinal (GM-611) on the gastrointestinal contractile activity in Rhesus monkeys in vivo and in vitro. Digestive Diseases and Sciences. doi: 10.1007/s10620-006-9672-5. 2007
   Google Scholar
• Yunker MH, Borodkin S. Determination of rate constants for in vitro three-compartment transfer using a two-phase system. Journal of Pharmaceutical Sciences 1971; 60: 52–56
   PubMed Web of Science ®Google Scholar